Company / Working Capital
Harmony Biosciences Holdings, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$654.9M
FY2025
5-year range
$230.7M / $654.9M
FY2021-FY2025
Trend
+62.0%
vs FY2024
Sector context
#68 of 213
Health Care
What the data says
At $655M, Harmony Biosciences Holdings, Inc.'s working capital ranks #68 of 213 in the Health Care sector. Improved from $287M to $655M over the past 2 years.
Based on SEC 10-K filings.
$655M in FY2025 with a 5-year CAGR of +38.5%.
Improved from $287M to $655M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +26.8%
- 5-Year CAGR
- +38.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 213 in Health CareTop 32% of 213This company $654.9M Sector average $934.6M
▼
-29.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.5%, indicating consistent growth.
- In FY2025, working capital increased 62.0% year-over-year.
- Ranks #68 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $654.9M | +62.0% |
| FY2024 | $404.2M | +40.7% |
| FY2023 | $287.3M | -10.6% |
| FY2022 | $321.4M | +39.3% |
| FY2021 | $230.7M | +79.7% |
| FY2020 | $128.4M | +1006.0% |
| FY2019 | $11.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026